What is NDC 67877-664?

67877-664 is the product NDC for Clobazam, Clobazam 5 mg/1 tablet, listed with the FDA by Ascend Laboratories, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Clobazam?

29 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Clobazam NDC 67877-664 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-664Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0664Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
67877-664-01	6787706640167877066401	1 BOTTLE in 1 CARTON (67877-664-01) / 100 TABLET in 1 BOTTLEMarketed from Oct 18, 2023
67877-664-05	6787706640567877066405	500 TABLET in 1 BOTTLE (67877-664-05)Marketed from Oct 18, 2023
67877-664-33	6787706643367877066433	1 BLISTER PACK in 1 CARTON (67877-664-33) / 10 TABLET in 1 BLISTER PACKMarketed from Oct 18, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clobazam
Generic name (nonproprietary): clobazam
Active ingredients: Clobazam — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ascend Laboratories, LLCNDC labeler code 67877
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212714
Marketing start: Oct 18, 2023
Listing expires: Dec 31, 2027
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)
Identifiers: Product ID 67877-664_f9dc8ac4-86be-49ab-9c2c-c60658f49d8fSPL ID f9dc8ac4-86be-49ab-9c2c-c60658f49d8fSPL set ID a77ffbdd-4e3e-4ec4-b0fa-b51ee610df0fRxCUI 199450, 246172, 427538UNII 2MRO291B4U
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877066401 followed by a unit qualifier and the quantity

Package 67877-0664-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 10, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Clobazam tablet is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older. Clobazam tablet is a benzodiazepine indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67877-664

What is NDC 67877-664?: 67877-664 is the product NDC for Clobazam, Clobazam 5 mg/1 tablet, listed with the FDA by Ascend Laboratories, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Clobazam.
What is the active ingredient?: Clobazam.
Who is the labeler?: Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Clobazam?: 29 other product NDCs are listed under this name. See all Clobazam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Clobazam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Precision Dose, Inc.	68094-074	68094-0074-58
Clobazam	Clobazam 10 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-047	72205-0047-91
Clobazam	Clobazam 20 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-048	72205-0048-91
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Aurobindo Pharma Limited	59651-401	59651-0401-12
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Bryant Ranch Prepack	72162-2608	72162-2608-02
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Sun Pharmaceutical Industries, Inc.	51672-4227	51672-4227-08
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Ascend Laboratories, LLC	67877-658	67877-0658-61
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	NorthStar RxLLC	16714-087	16714-0087-01
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Chartwell RX, LLC	62135-527	62135-0527-41
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Camber Pharmaceuticals, Inc.	31722-641	31722-0641-12

All 30 Clobazam NDCs

Other NDCs under ANDA 212714

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212714
Product	Strength	Form · route	Labeler	Product NDC
Clobazam	Clobazam 10 mg/1	TabletOral	Ascend Laboratories, LLC	67877-665
Clobazam	Clobazam 20 mg/1	TabletOral	Ascend Laboratories, LLC	67877-666